IMNM
IMNM
US45257U1088
Immunome, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
2.31B EUR
2.4B EUR
2.48B EUR
2.43B EUR
Enterprise Value
1.68B EUR
2.19B EUR
1.9B EUR
1.78B EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
-8.06x
--
--
--
Price to Sales
-
--
616.45x
605.26x
Price to Book
4.22x
4.58x
4.2x
3.83x
EV/Revenue
--
--
472.24x
443.46x
EV/EBITDA
-6.51x
--
--
--
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
-6.23%
-9.49%
-8.67%
-5.92%
ende